D-0021-2025 Class II Terminated

Recalled by Fresenius Kabi Compounding, LLC — Canton, MA

FDA drug recall D-0021-2025 was initiated by Fresenius Kabi Compounding, LLC on Sep 25, 2024 and is designated Class II. Reason for recall: cGMP violations The recall status is terminated (terminated Aug 15, 2025). Affected quantity: 4436 bags.

Recall details

Product Type
Drugs
Report Date
Oct 30, 2024
Initiation Date
Sep 25, 2024
Termination Date
Aug 15, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4436 bags

Product description

Oxytocin 0.9% Sodium Chloride Injection USP, 30 units per 500 mL Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-028-59

Reason for recall

cGMP violations

Distribution pattern

Product was distributed to 125 direct accounts nationwide.

Code information

Lot # C274-000038801, exp. date 9-Oct-24 C274-000039045, exp. date 24-Oct-24 C274-000039240, exp. date 31-Oct-24

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0021-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0021-2025. Report a data issue: hello@regdatalab.com.